Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ASTRAZENECA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ASTRAZENECA PHARMA SANOFI INDIA/
ASTRAZENECA PHARMA
 
P/E (TTM) x 33.4 197.0 17.0% View Chart
P/BV x 15.0 22.8 65.9% View Chart
Dividend Yield % 2.7 0.4 728.4%  

Financials

 SANOFI INDIA   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-23
ASTRAZENECA PHARMA
Mar-24
SANOFI INDIA/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs8,2787,208 114.8%   
Low Rs5,2403,102 168.9%   
Sales per share (Unadj.) Rs1,238.0518.2 238.9%  
Earnings per share (Unadj.) Rs261.864.6 405.2%  
Cash flow per share (Unadj.) Rs279.070.6 395.3%  
Dividends per share (Unadj.) Rs167.0024.00 695.8%  
Avg Dividend yield %2.50.5 530.7%  
Book value per share (Unadj.) Rs411.2283.5 145.1%  
Shares outstanding (eoy) m23.0325.00 92.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.59.9 54.9%   
Avg P/E ratio x25.879.8 32.4%  
P/CF ratio (eoy) x24.273.0 33.2%  
Price / Book Value ratio x16.418.2 90.4%  
Dividend payout %63.837.1 171.7%   
Avg Mkt Cap Rs m155,659128,875 120.8%   
No. of employees `000NANA-   
Total wages/salary Rs m3,7062,415 153.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m28,51112,955 220.1%  
Other income Rs m665348 191.1%   
Total revenues Rs m29,17613,303 219.3%   
Gross profit Rs m8,2032,009 408.4%  
Depreciation Rs m396149 265.1%   
Interest Rs m1712 141.7%   
Profit before tax Rs m8,4552,195 385.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,426580 418.1%   
Profit after tax Rs m6,0291,615 373.3%  
Gross profit margin %28.815.5 185.6%  
Effective tax rate %28.726.4 108.6%   
Net profit margin %21.112.5 169.6%  
BALANCE SHEET DATA
Current assets Rs m31,31410,427 300.3%   
Current liabilities Rs m25,3474,672 542.6%   
Net working cap to sales %20.944.4 47.1%  
Current ratio x1.22.2 55.3%  
Inventory Days Days15947 337.1%  
Debtors Days Days1743 39.1%  
Net fixed assets Rs m15,7142,342 671.1%   
Share capital Rs m23050 460.0%   
"Free" reserves Rs m9,2397,036 131.3%   
Net worth Rs m9,4697,086 133.6%   
Long term debt Rs m00-   
Total assets Rs m47,02812,769 368.3%  
Interest coverage x498.4184.0 270.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.0 59.8%   
Return on assets %12.912.7 100.9%  
Return on equity %63.722.8 279.4%  
Return on capital %89.531.2 287.2%  
Exports to sales %18.00-   
Imports to sales %25.20.5 5,346.0%   
Exports (fob) Rs m5,143NA-   
Imports (cif) Rs m7,17761 11,765.1%   
Fx inflow Rs m5,1431,094 470.1%   
Fx outflow Rs m7,17761 11,765.1%   
Net fx Rs m-2,0341,033 -196.9%   
CASH FLOW
From Operations Rs m2,304279 826.7%  
From Investments Rs m375217 172.5%  
From Financial Activity Rs m-8,783-444 1,979.0%  
Net Cashflow Rs m-6,10452 -11,671.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 75.0 80.5%  
Indian inst/Mut Fund % 28.4 8.0 355.0%  
FIIs % 5.8 2.9 199.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 25.0 158.4%  
Shareholders   66,211 27,615 239.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Sanofi India vs ASTRAZENECA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Sanofi India vs ASTRAZENECA PHARMA Share Price Performance

Period Sanofi India ASTRAZENECA PHARMA S&P BSE HEALTHCARE
1-Day 1.88% 1.87% 0.67%
1-Month -3.10% -9.59% 0.99%
1-Year -23.18% 35.91% 45.87%
3-Year CAGR -8.97% 28.55% 19.53%
5-Year CAGR -2.34% 18.73% 26.06%

* Compound Annual Growth Rate

Here are more details on the Sanofi India share price and the ASTRAZENECA PHARMA share price.

Moving on to shareholding structures...

The promoters of Sanofi India hold a 60.4% stake in the company. In case of ASTRAZENECA PHARMA the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Sanofi India and the shareholding pattern of ASTRAZENECA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Sanofi India paid a dividend of Rs 167.0 per share. This amounted to a Dividend Payout ratio of 63.8%.

ASTRAZENECA PHARMA paid Rs 24.0, and its dividend payout ratio stood at 37.1%.

You may visit here to review the dividend history of Sanofi India, and the dividend history of ASTRAZENECA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4% Sensex Today Zooms Over 1,200 Points | Nifty Above 24,300 | Adani Ports Climbs 4%(10:30 am)

Asian stocks experienced a notable rally alongside US equity futures on Monday, marking a positive turn for the markets. The dollar retreated against other currencies as bond yields declined.